Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia

Neuroscience Letters

Volumn 505, Issue 1, 2011, Pages 47-51

  Gigante, A D ^a,b   Andreazza, A C ^c,d   Lafer, B ^b   Yatham, L N ^a   Beasley, C L ^a   Young, L T ^c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bipolar disorder; Oxidative stress; Postmortem; Schizophrenia; Superoxide dismutase; Uncoupling protein 2

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; UNCOUPLING PROTEIN 2;

ADULT; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SCHIZOPHRENIA;

ADULT; BIPOLAR DISORDER; FEMALE; HUMANS; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POSTMORTEM CHANGES; PREFRONTAL CORTEX; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 82455162414     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.064     Document Type: Article

References (46)

1. Akyol O., Yanik M., Elyas H., Namli M., Canatan H., Akin H., Yuce H., Yilmaz H.R., Tutkun H., Sogut S., Herken H., Ozyurt H., Savas H.A., Zoroglu S.S. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:123-131.
2. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., Yatham L.N. Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect. Disord. 2008, 111:135-144.
3. Andreazza A.C., Shao L., Wang J.F., Young L.T. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 2010, 67:360-368.
4. Andrews Z.B., Diano S., Horvath T.L. Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nat. Rev. Neurosci. 2005, 6:829-840.
5. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 2000, 26:435-439.
6. Baek J.H., Park D.Y., Choi J., Kim J.S., Choi J.S., Ha K., Kwon J.S., Lee D., Hong K.S. Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history. J. Affect. Disord. 2011, 131:59-67.
7. Benes F.M., Matzilevich D., Burke R.E., Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry 2006, 11:241-251.
8. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., Yucel M., Gama C.S., Dodd S., Dean B., Magalhaes P.V., Amminger P., McGorry P., Malhi G.S. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 2011, 35:804-817.
9. Bo H., Jiang N., Ma G., Qu J., Zhang G., Cao D., Wen L., Liu S., Ji L.L., Zhang Y. Regulation of mitochondrial uncoupling respiration during exercise in rat heart: role of reactive oxygen species (ROS) and uncoupling protein 2. Free Radic. Biol. Med. 2008, 44:1373-1381.
10. Buttner N., Bhattacharyya S., Walsh J., Benes F.M. DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr. Res. 2007, 93:33-41.
11. Che Y., Wang J.F., Shao L., Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J. Psychiatry Neurosci. 2010, 35:296-302.
12. Chevillotte E., Rieusset J., Roques M., Desage M., Vidal H. The regulation of uncoupling protein-2 gene expression by omega-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor beta. J. Biol. Chem. 2001, 276:10853-10860.
13. Chowdari K.V., Bamne M.N., Nimgaonkar V.L. Genetic association studies of antioxidant pathway genes and schizophrenia. Antioxid. Redox Signal. 2011, 15:2037-2045.
14. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 2010.
15. Cortez-Pinto H., Zhi Lin H., Qi Yang S., Odwin Da Costa S., Diehl A.M. Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 1999, 116:1184-1193.
16. Diano S., Matthews R.T., Patrylo P., Yang L., Beal M.F., Barnstable C.J., Horvath T.L. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 2003, 144:5014-5021.
17. Dikov D., Aulbach A., Muster B., Drose S., Jendrach M., Bereiter-Hahn J. Do UCP2 and mild uncoupling improve longevity?. Exp. Gerontol. 2010, 45:586-595.
18. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., Harper J.A., Roebuck S.J., Morrison A., Pickering S., Clapham J.C., Brand M.D. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415:96-99.
19. Fullerton J.M., Tiwari Y., Agahi G., Heath A., Berk M., Mitchell P.B., Schofield P.R. Assessing oxidative pathway genes as risk factors for bipolar disorder. Bipolar Disord. 2010, 12:550-556.
20. Galluzzi L., Blomgren K., Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat. Rev. Neurosci. 2009, 10:481-494.
21. Gawryluk J.W., Wang J.F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int. J. Neuropsychopharmacol. 2010, 1-8.
22. Gigante A.D., Young L.T., Yatham L.N., Andreazza A.C., Nery F.G., Grinberg L.T., Heinsen H., Lafer B. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 2010, 1-15.
23. Halliwell B., Gutteridge J.M. Free radicals, lipid peroxidation, and cell damage. Lancet 1984, 2:1095.
24. Hamakawa H., Murashita J., Yamada N., Inubushi T., Kato N., Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin. Neurosci. 2004, 58:82-88.
25. Harada S., Tachikawa H., Kawanishi Y. Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem. Biophys. Res. Commun. 2001, 281:267-271.
26. Harada S., Tachikawa H., Kawanishi Y. A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia. Psychiatr. Genet. 2003, 13:205-209.
27. Jendrach M., Mai S., Pohl S., Voth M., Bereiter-Hahn J. Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 2008, 8:293-304.
28. Kato T. Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?. Trends Neurosci. 2008, 31:495-503.
29. Kato T., Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000, 2:180-190.
30. Kato T., Takahashi S., Shioiri T., Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J. Affect. Disord. 1992, 26:223-230.
31. Ketter T.A. Diagnostic features, prevalence, and impact of bipolar disorder. J. Clin. Psychiatry 2010, 71:e14.
32. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 2004, 61:300-308.
33. Liu H., Wang C., Chen P.H., Zhang B.S., Zheng Y.L., Zhang C.X., Meng H.Q., Wang Y., Chen Da C., Xiu M.H., Kosten T.R., Zhang X.Y. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:692-696.
34. Michel T.M., Thome J., Martin D., Nara K., Zwerina S., Tatschner T., Weijers H.G., Koutsilieri E. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. J. Neural Transm. 2004, 111:1191-1201.
35. Nègre-Salvayre A., Hirtz C., Carrera G., Cazenave R., Troly M., Salvayre R., Pénicaud L., Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 1997, 11:809-815.
36. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 2008, 11:851-876.
37. Pae C.U., Kim T.S., Patkar A.A., Kim J.J., Lee C.U., Lee S.J., Jun T.Y., Lee C., Paik I.H. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia. Psychiatry Res. 2007, 153:77-81.
38. Pae C.U., Yoon S.J., Patkar A., Kim J.J., Jun T.Y., Lee C., Paik I.H. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism and mood disorders: a preliminary study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:1326-1329.
39. Pae C.U., Yoon S.J., Patkar A.A., Kim J.J., Lee C., Paik I.H. Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders. Psychiatry Res. 2007, 153:83-86.
40. Pae C.U., Yu H.S., Kim J.J., Lee C.U., Lee S.J., Jun T.Y., Lee C., Paik I.H. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int. J. Neuropsychopharmacol. 2004, 7:495-500.
41. Sullivan P.G., Dubé C., Dorenbos K., Steward O., Baram T.Z. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann. Neurol. 2003, 53:711-717.
42. Sun X., Wang J.F., Tseng M., Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J. Psychiatry Neurosci. 2006, 31:189-196.
43. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 2000, 44:151-155.
44. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009, 11:523-529.
45. Washizuka S., Kakiuchi C., Mori K., Kunugi H., Tajima O., Akiyama T., Nanko S., Kato T. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 120B:72-78.
46. Zhang M., Zhao Z., He L., Wan C. A meta-analysis of oxidative stress markers in schizophrenia. Sci. China Life. Sci. 2010, 53:112-124.